A meta-analysis by Hu et al. concluded a significant correlation between CTLA-4 and OS in nasopharyngeal carcinoma, malignant hematologic diseases, and glioblastoma, most of which had a strong pooled hazard ratio (HR). Here, CTLA4 is linked to glioblastoma.